Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Atul Pande currently holds 7,061 shares of Axovant Gene Therapies Ltd. (AXGT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Atul Pande has been a net seller of AXGT stock. They have purchased $210.0K and sold $8.0M worth of shares.
Atul Pande's most recent insider trade was on Apr 7, 2026, when they sold 7,061 shares at $0.00 per share.
Atul Pande serves as Executive at Axovant Gene Therapies Ltd. (AXGT). They have executed 66 insider transactions totaling $8.2M over their tenure at the company.
Atul Pande holds the position of Executive at Axovant Gene Therapies Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Atul Pande has shown a selling trading pattern, with $210.0K in total purchases and $8.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Atul Pande was on Mar 18, 2024, when they sold $2.9M worth of KRTX shares. This transaction involved 12,500 shares at $232.41 per share.
Atul Pande currently owns 7,061 shares of Axovant Gene Therapies Ltd. (AXGT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Atul Pande's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Atul Pande has 66 Form 4 filings on record as an insider at Axovant Gene Therapies Ltd..
Set alerts for Atul Pande and 40,000+ other insiders.